These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32819877)

  • 1. The U.S. medicine chest: Understanding the U.S. pharmaceutical supply chain and the role of the pharmacist.
    Costantino RC
    J Am Pharm Assoc (2003); 2021; 61(1):e87-e92. PubMed ID: 32819877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When government agencies turn to unregulated drug sources: Implications for the drug supply chain and public health are grave.
    Yadav P; Weintraub RL; Stergachis A
    J Am Pharm Assoc (2003); 2018; 58(5):477-480. PubMed ID: 30077566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing pharmacists' preference for the legal classification of Rx-to-OTC switched drug products.
    Madhaven S
    J Clin Pharm Ther; 1993 Aug; 18(4):281-90. PubMed ID: 8227236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U.S. Public Health Service Commissioned Corps pharmacists: making a difference in advancing the nation's health.
    Flowers L; Wick J; Figg WD; McClelland RH; Shiber M; Britton JE; Ngo DK; Borders-Hemphill V; Mead C; Zee J; Huntzinger P
    J Am Pharm Assoc (2003); 2009; 49(3):446-52. PubMed ID: 19443327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformational strategies for optimizing use of medications and related therapies through us pharmacists and pharmacies: Findings from a national study.
    Thornewill J; Antimisiaris D; Ezekekwu E; Esterhay R
    J Am Pharm Assoc (2003); 2022; 62(2):450-460. PubMed ID: 34758925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles for pharmacy in combatting counterfeit drugs.
    Ziance RJ
    J Am Pharm Assoc (2003); 2008; 48(4):e71-88; quiz e89-91. PubMed ID: 18653407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the pharmacist in preventing distribution of counterfeit medications.
    Chambliss WG; Carroll WA; Kennedy D; Levine D; Moné MA; Ried LD; Shepherd M; Yelvigi M
    J Am Pharm Assoc (2003); 2012; 52(2):195-9. PubMed ID: 22370383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing patient care through formulary and drug shortage management.
    Pulk RA; Leber M; Tran L; Ammar M; Amin N; Miller L; Yazdi M
    Am J Health Syst Pharm; 2020 Oct; 77(22):1874-1884. PubMed ID: 32710774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
    Shepherd MD
    J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing pharmacist prescribing privileges: Is it time?
    Majercak KR
    J Am Pharm Assoc (2003); 2019; 59(6):783-786. PubMed ID: 31521588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of current and potential public health involvement of pharmacists in developing nations: The case of Zimbabwe.
    Mdege ND; Chevo T; Toner P
    Res Social Adm Pharm; 2016; 12(6):876-884. PubMed ID: 26703215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic justification for a public school of pharmacy: lessons for Nevada.
    Matthews J; Pingle M; Sullivan R; Ferguson P; Rogers JE; Buxton IL
    Proc West Pharmacol Soc; 2005; 48():1-12. PubMed ID: 16416651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacist perceptions of increased technician responsibility.
    Sparkmon W; Barnard M; Rosenthal M; Desselle S; Holmes E
    J Am Pharm Assoc (2003); 2021; 61(4):382-389.e4. PubMed ID: 33853751
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.